z-logo
Premium
Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers
Author(s) -
Iijima Hironobu,
Tomizawa Yoshio,
Iwasaki Yasuki,
Sato Koji,
Sunaga Noriaki,
Dobashi Kunio,
Saito Ryusei,
Nakajima Takashi,
Minna John D.,
Mori Masatomo
Publication year - 2005
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.21462
Subject(s) - trichostatin a , lung cancer , cancer research , biology , epigenetics , frameshift mutation , loss of heterozygosity , gene , microbiology and biotechnology , mutation , genetics , allele , pathology , medicine , histone deacetylase , histone
Allelic loss on the short arm of chromosome 3 is one of the most common events in the pathogenesis of lung cancer. The lactotransferrin gene ( LTF, also referred to as the lactoferrin gene, LF ) is located at 3p21.3 common eliminated region 1, which is frequently deleted in lung and other cancers. The expression of the LTF gene was absent in 16 (59%) of 27 small cell lung cancer cell lines, 33 (77%) of 43 nonsmall‐cell lung cancer (NSCLC) cell lines and 7 (54%) of 13 primary NSCLC, while LTF mRNA was overexpressed in 3 (7%) of 43 NSCLC cell lines. Its expression was restored by treatment with 5‐aza‐2′‐deoxycytidine (5‐aza‐dC), trichostatin A (TSA) or a combination of both in a subset of lung cancer cell lines without LTF expression. In addition, we found 8 different types of nucleotide substitutions and one frameshift mutation. These results indicate that the LTF gene is inactivated by genetic and epigenetic mechanisms in lung cancer. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom